Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

Lignende værker

• Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)()
  af: DeZern, Amy E., et al.
  Udgivet: (2016)
• Outcome of Patients With Low-Risk and Intermediate-1-Risk Myelodysplastic Syndrome After Hypomethylating Agent Failure A Report on Behalf of the MDS Clinical Research Consortium
  af: Jabbour, Elias J., et al.
  Udgivet: (2014)
• Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
  af: Zeidan, Amer M., et al.
  Udgivet: (2015)
• Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents
  af: Nazha, Aziz, et al.
  Udgivet: (2015)
• The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
  af: Nazha, Aziz, et al.
  Udgivet: (2016)